Comparison of apolipoprotein (apoB/apoA-I) and lipoprotein (Total Cholesterol/HDL) ratio determinants. focus on obesity, diet and alcohol intake

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Tognon, Gianluca ^a   Berg, Christina ^a   Mehlig, Kirsten ^a   Thelle, Dag ^a,b   Strandhagen, Elisabeth ^a   Gustavsson, Jaana ^a   Rosengren, Annika ^a   Lissner, Lauren ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; RISK FACTOR; SEX DIFFERENCE; SWEDEN;

ADULT; ALCOHOL DRINKING; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIET; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; OBESITY; SMOKING;

EID: 84864651487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040878     Document Type: Article

References (38)

1. NCEP (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
2. Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G, (2006) Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease. J Intern Med 259: 455-461.
3. Walldius G, Jungner I, (2006) The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Intern Med 259: 493-519.
4. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, et al. (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376: 112-123.
5. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, et al. (2008) Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 372: 224-233.
6. Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, et al. (2008) Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 117: 3002-3009.
7. Steinmetz J, Caces E, Couderc R, Beucler I, Legrand A, et al. (1997) [Reference values of apolipoproteins A1 and B. Contribution of international standardization. Travail collaboratif entre la SFBC, l'Arcol et le SFRL]. Ann Biol Clin (Paris) 55: 451-454.
8. Denke MA, (2005) Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy. Circulation 112: 3368-3370.
9. Kargman DE, Tuck C, Berglund L, Lin IF, Mukherjee RS, et al. (1998) Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 139: 391-399.
10. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, et al. (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302: 1993-2000.
11. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, et al. (2009) Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 119: 931-939.
12. Arsenault BJ, Despres JP, Stroes ES, Wareham NJ, Kastelein JJ, et al. (2010) Lipid assessment, metabolic syndrome and coronary heart disease risk. Eur J Clin Invest 40: 1081-1093.
13. van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, et al. (2007) Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk. Ann Intern Med 146: 640-648.
14. Kappelle PJ, Gansevoort RT, Hillege JL, Wolffenbuttel BH, Dullaart RP, (2011) Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein. J Intern Med 269: 232-242.
15. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, et al. (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366: 1640-1649.
16. Simonsson M, Schmidt C, Sigurdadottir V, Helenius ML, Fagerberg B, (2007) Life style habits such as alcohol consumption and physical activity in relation to serum apoB/apoA-I ratio amongst 64-year-old women with varying degrees of glucose tolerance. J Intern Med 262: 537-544.
17. Berg C, Rosengren A, Aires N, Lappas G, Toren K, et al. (2005) Trends in overweight and obesity from 1985 to 2002 in Goteborg, West Sweden. Int J Obes (Lond) 29: 916-924.
18. Strandhagen E, Berg C, Lissner L, Nunez L, Rosengren A, et al. (2010) Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol 25: 163-172.
19. Messerer M, Johansson SE, Wolk A, (2004) The validity of questionnaire-based micronutrient intake estimates is increased by including dietary supplement use in Swedish men. J Nutr 134: 1800-1805.
20. Wolk A, Ljung H, Vessby B, Hunter D, Willett WC, (1998) Effect of additional questions about fat on the validity of fat estimates from a food frequency questionnaire. Study Group of MRS SWEA. Eur J Clin Nutr 52: 186-192.
21. Berg CM, Lissner L, Aires N, Lappas G, Toren K, et al. (2005) Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil 12: 115-125.
22. Kaluza J, Hakansson N, Brzozowska A, Wolk A, (2009) Diet quality and mortality: a population-based prospective study of men. Eur J Clin Nutr 63: 451-457.
23. WHO/FAO. Diet, nutrition and the Prevention of Chronic Diseases. Joint WHO/FAO Expert Consultation. No. 916, Geneva, 2003.
24. Aires N, Selmer R, Thelle D, (2003) The validity of self-reported leisure time physical activity, and its relationship to serum cholesterol, blood pressure and body mass index. A population based study of 332,182 men and women aged 40-42 years. Eur J Epidemiol 18: 479-485.
25. Saltin B, Grimby G, (1968) Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages. Circulation 38: 1104-1115.
26. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, et al. (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32: S498-504.
27. WHO (2000) Obesity: Preventing and managing the global epidemic. Report on a WHO Consultation. Technical Report Series No. 894. World Health Organization, Geneva.
28. Willett WC, (1998) Nutritional epidemiology. 2nd edition: New York: Oxford University Press.
29. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, et al. (1990) A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322: 882-889.
30. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, et al. (1990) High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 322: 95-99.
31. Sesso HD, (2001) Alcohol and cardiovascular health: recent findings. Am J Cardiovasc Drugs 1: 167-172.
32. Volcik KA, Ballantyne CM, Fuchs FD, Sharrett AR, Boerwinkle E, (2008) Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol 18: 101-107.
33. Brinton EA, (2010) Effects of ethanol intake on lipoproteins and atherosclerosis. Curr Opin Lipidol 21: 346-351.
34. Mehlig K, Skoog I, Guo X, Schutze M, Gustafson D, et al. (2008) Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg. Am J Epidemiol 167: 684-691.
35. Berg C, Lappas G, Strandhagen E, (2008) Food patterns and cardiovascular disease risk factors: the Swedish INTERGENE research program. American journal of.
36. Berg C, Lappas G, Strandhagen E, (2008) Food patterns and cardiovascular disease risk factors: the Swedish INTERGENE research program. American journal of.
37. Berg C, Lappas G, Wolk A, Strandhagen E, Torén K, et al. (2009) Eating patterns and portion size associated with obesity in a Swedish population. Appetite 52: 21-27.
38. Berg C, Rosengren A, Aires N, Lappas G, Torén K, et al. (2005) Trends in overweight and obesity from 1985 to 2002 in Göteborg, West Sweden. Int J Obes 29.